Subscribe to Medpace Corporate’s news feed.
Click on “Follow” and decide if you want to get news from Medpace Corporate via RSS, as email newsletter, via mobile or on your personal news page.
Subscription to Medpace Corporate comes without risk as you can unsubscribe instantly at any time.
You can also filter the feed to your needs via topics and keywords so that you only receive the news from Medpace Corporate which you are really interested in. Click on the blue “Filter” button below to get started.
Website title: Drug and Biologic Contract Research Organization (CRO) | Medpace
Is this your feed? Claim it!
Retina development continues to be driven by converging scientific, demographic, and commercial forces. With a rapidly growing patient population, and strong investor interest, there is a push for more assets into the pipeline and reshaping expectations for trial design and market access.
Retinal disease is no longer niche. Age-related macular degeneration (AMD) al...
As clinical trials continue to expand across Asia-Pacific, Sponsors need a laboratory partner with both regional expertise and globally standardized operations. Since joining Medpace in 2018, Paul Tan, PhD, Senior Director, Clinical Laboratory Services, Medpace Singapore and Shangai, has helped strengthen Medpace’s laboratory capabilities throughou...
In July 2026, the third Alport Research Hub Symposium took place at the Institute of Child Health in London. Organized by Kidney Research UK, this symposium brought together preclinical researchers, medical doctors, representatives from patient advocacy associations and pharmaceutical companies to discuss the latest advances in Alport syndrome research. Medpace was represente...